Практические Рекомендации по Адекватности Гемодиализа


VII. Литература

1. Committee to Advise the Public Health Service on Clinical Practice Guidelines, in Field, MJ, Lohr, KN (eds): Clinical Practice Guidelines: Directions for a New Program. Washington, DC, National Academy Press, 1990, 168 pp

2. American Medical Association/Specialty Society Practice Parameters Partnership Attributes to Guide the Development and Evaluation of Practice Pararmeters/Guidelines., 1996, pp 1-10

3. U.S. Renal Data System: Treatment modalities for ESRD patients. in National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases (eds): U.S. Renal Data System 1996 Annual Data Report. 3. Bethesda, MD, 1996, pp 33-47

4. Held PJ, Akiba T, Stearns NS, Marumo F, Turenne MN, Maeda K, Port FK: Survival of middle aged dialysis patients in Japan and the US,1988-89. in Friedman EA (ed):Death on Hemodialysis: Preventable or Inevitable? 2. Boston, MA, Kluwer Academic Publishers, 1994, pp 13-23

5. Hull AR, Parker TF, III: Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, TX , September 15 to 17, 1989. Am J Kidney Dis 15:3775-383, 1990

6. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS: Five year survival for end stage renal patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15:451-457, 1990

7. U.S. Renal Data System. Patient mortality and survival, in National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases, (eds): U.S. Renal Data System 1996 Annual Data Report. Bethesda, MD. 1996; 3, pp 69-84

8. Collins AJ, Hanson G, Umen A, Kjellstrand C, Keshaviah P: Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 15:422-432, 1990

9. Keane WF, Collins AJ: Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24:1010-1018, 1994

10. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of dialysis associated diseases in the United States, 1991. ASAIO J 39:966-975, 1993

11. Shaldon S: Unanswered questions pertaining to dialysis adequacy in 1992. Kidney Int Suppl 41:S274-S277, 1993

12. Hull AR: Predictors of the excessive mortality rates of dialysis patients in the United States. Curr Opin Nephrol Hypertens 3:286-291, 1994

13. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990

14. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993

15. Kjellstrand CM: International comparisons of dialysis survival are meaningless to evaluate differences in dialysis procedures. in Friedman EA (ed):Death on Hemodialysis: Preventable or Inevitable? 6. Boston, MA, Kluwer Academic Publishers, 1994, pp 55-68

16. Wolfe RA, Mauger A, Held PJ, Golper T, Sarsitis I, Woods JD, Agoadoa LYC, Port FK: Patient mix and mortality in chronic hemodialysis. J Am Soc Nephrol 6:568, 1995 (abstr)

17. Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N: The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int Suppl 42:S16-S21, 1992

18. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH: Mortality and duration of hemodialysis treatment. JAMA 265:871-875, 1991

19. Parker TF, Husni L: Delivering the prescribed dialysis. Sem Dial 6:13-15, 1993

20. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23:272-282, 1994

21. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity. N Engl J Med 305:1176-1180, 1981

22. Hakim RM: Assessing the adequacy of dialysis. Kidney Int 37:822-832, 1990

23. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994

24. Acchiardo SR, Hatten KW, Ruvinsky MJ, Dyson B, Fuller J, Moore LW: Inadequate dialysis increases gross mortality rate. ASAIO J 38:M282-M285, 1992

25. Lowrie EG: Chronic dialysis treatment: Clinical outcome and related processes of care. Am J Kidney Dis 24:255-266, 1994

26. Fernandez JM, Carbonell ME, Mazzuchi N, Petruccelli D: Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 41:1029-1034, 1992

27. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 50:550-556, 1996

28. Parker T, Husni L, Huang W, Lew N, Lowrie EG, Dallas Nephrology Associates. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23:670-680, 1994

29. Opportunities to improve care for adult in center hemodialysis patients. Washington DC, Department of Health and Human Services, pp 1-42, 1996 Department of Health and Human Services, Health Care Financing Administration, Health Standards and Quality Bureau: Anonymous (ed 1996 Annual Report)

30. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt-V: An analysis of error. J Am Soc Nephrol 4:1205-1213, 1993

31. Flanigan MJ, Fangman J, Lim VS: Quantitating hemodialysis: A comparison of three kinetic models. Am J Kidney Dis 17:295-302, 1991

32. Daugirdas JT: Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Advances in Renal Replacement Therapy 2:295-304, 1995

33. Gotch FA: Kinetic modeling in hemodialysis. in Nissenson AR, Fine RN, Gentile DE (eds): Clinical Dialysis. 8. (ed 3rd)Englewood Cliffs, NJ, Prentice Hall, 1995, pp 156-189

34. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526-534, 1985

35. Renal Physician's Association Clinical Practice Guideline Working Committee: In Renal Physician's Association (ed):Clinical Practice Guideline on Adequacy of Hemodialysis. Clinical Practice Guideline, Number 1. Dubuque, IA, Kendall/Hunt Publishing, 1996, pp 1-1027

36. Depner T: Assessing the adequacy of hemodialysis: Urea modeling. Kidney Int 45:1522-1535, 1994

37. Hakim RM, Depner TA, Parker TF, III: Adequacy of hemodialysis. Am J Kidney Dis 20:107-123, 1992

38. Sargent JA: Shortfalls in the delivery of dialysis. Am J Kidney Dis 15:500-510, 1990

39. Owen WF, Meyer KA, Schmidt G, Alfred H, and the Medical Review Board of New England: Methodological limitations of quality surveys in the ESRD program. J Am Soc Nephrol, 1997 (In press)

40. 1995 ESRD Assessment Project, Network 16. A description of adult, in-center hemodialysis units in a five state network and their capacity to provide adequate dialyisis. Seattle, WA, Health Care Financing Association, pp 1-16, 1995

41. U.S. Renal Data System: The USRDS dialysis morbidity and mortality study (wave 1). in National Institute of Health, National Institute Diabetes and Digestive and Kidney Diseases (eds): USRDS Annual Data Report 1997, chap 4. Bethesda, MD, 1997, pp 45-67

42. Pedrini LA, Zereik S, Rasmy S: Causes, kinetics and clinical implications of post-hemodialysis urea rebound. Kidney Int 34:817-824, 1988

43. Daugirdas JT, Schneditz D, Leehey DJ: Effect of access recirculation on the modeled urea distribution volume. Am J Kidney Dis 27:512-518, 1996

44. U.S. Renal Data System: Reference tables: Methods of treatment. in National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases (eds): U.S. Renal Data System 1994 Annual Data Report. Bethesda, MD, 1994, pp C5

45. U.S. Renal Data System. Incidence and prevalence of ESRD, in National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases, (eds): U.S. Renal Data System 1996 Annual Data Report. Bethesda, MD. 1996; 3, pp 17-31

46. Ogden DA, Friedl MM: Simultaneous reprocessing of hollow fiber dialyzers and blood tubing sets for multiple use. Dial Transplant 13:366-375, 1984

47. Ing TS, Cheung AK, Golper TA, Lang GR, Lazarus JM, Letteri JM, Levin NW, Lundin AP, Molony DA, Mujais SK, Port FK, Ward RA: National Kidney Foundation report on dialyzer reuse. Am J Kidney Dis 1997 (In Press)

48. Tokars J, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA: National surveillance of dialysis associated disease in the United States, 1994. ASAIO J 42:119-129, 1996

49. Sherman RA, Cody RP, Rogers ME, Solanchick JC: The effect of dialyzer reuse on dialysis delivery. Am J Kidney Dis 24:924-926, 1994

50. Anonymous Dialyzers transport properties and germicidal elution. New York, NY, National Nephrology Foundation, 1984, Seminar on the reuse of hemodialyzers and automated and manual methods

51. Farrell PC, Eschbach JW, Vizzo JE, Babb AL: Hemodialyzer reuse: Estimation of urea loss from clearance data. Kidney Int 5:446-450, 1974

52. Multiple use of hemodialyzers (a report to the National Institute of Arthritis, Diabetes, Digestive and Kidney Disease), in Deane N, Beamis JA: (eds): New York, NY, Manhatttan Kidney Center Report NO1-AM-9-2214 1981

53. Standards and recommended practices for reuse of hemodialyzers. AAMI, Association for Advancement of Medical Information (AAMI), ANSI/AAMI RD-47 pp 106-107, 1993

54. Schoels M, Jahn B, Hug F, Deppisch R., Ritz E, Hansch GM: Stimulation of mononuclear cells by contact with cuprophan membranes: Further increase of beta 2-microglobulin synthesis by activated late complement components. Am J Kidney Dis 21:394-399, 1993

55. van Ypersele de Strihou, Jadoul M, Malghem J, Jamart J, Working party on Dialysis Amyloidosis. Effect of dialysis membrane and a patient's age on signs of dialysis-related amyloidosis. Kidney Int 39:1012-1019, 1991

56. Koch KM: Dialysis-related amyloidosis (clinical conference). Kidney Int 41:1416-1429, 1992

57. Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3:1409-1415, 1993

58. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daurgirdas JT, Kusek JW, Levin NW, Schulman G: Hemodialysis (HEMO) Study: Rationale for selection of interventions. Sem Dial 9:24-33, 1996

59. Lazarus JM, Owen WF: Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 24:1019-1032, 1994

60. Hakim RM: Clinical implications of hemodialysis membrane: Effect of chronic complement activation. Kidney Int 44:484-494, 1993

61. Hakim R, Fearon DT, Lazarus JM: Biocompatibility of dialysis membranes: Effect of chronic complement activation. Kidney Int 26:194-200, 1984

62. Himmelfarb J, Gerard NP, Hakim RM: Intradialytic modulation of granulocyte C5a receptors. J Am Soc Nephrol 2:920-926, 1991

63. Hakim RM, Breillatt J, Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311:878-882, 1984

64. Craddock PR, Fehr J, Dalmasso AP, Bringham KL, Jacob HS: Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59:879-888, 1977

65. Cheung AK: Adsorption of unactivated complement proteins by hemodialysis membranes. Am J Kidney Dis 14:472-477, 1989

66. Himmelfarb J, Lazarus J, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 17:271-276, 1991

67. Vanholder R, Ringoir S: Infectious morbidity and defects of phagocytic function in end-stage renal disease; a review. J Am Soc Nephrol 3:1541-1554, 1993

68. Vanholder R, Dell'Aquila R, Jacobs V, Dhondt A, Veys N, Waterloss MA, van Landschoot N, van Biesen W, Ringoin S: Depressed phagocytosis in hemodialyzed patients: In vivo and in vitro mechanisms. Nephron 63:409-415, 1993

69. Vanholder R, Van Loo A, Dhondt AM, Ringoir S: The role of dialysis membranes in infection. Nephrol Dial Transplant 11:101-103, 1996

70. Parker TF, Wingard RL, Husni L, Ikizler TA, Parker RA: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 49:551-556, 1996

71. Himmelfarb J, Hakim RM: Biocompatibility and risk of infection in haemodialysis patients. Nephrol Dial Transplant 9:138-144, 1994

72. Levin NW, Zasuwa G: Relationship between dialyser type and signs and symptoms. Nephrol Dial Transplant 8:30-39, 1993

73. Lazarus JM, Hakim RM: Timing the initiation of dialysis. J Am Soc Nephrol 6:1319-1328, 1996

74. CANUSA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1995

75. Lindsay RM, Spanner E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 13 (Suppl):382-389, 1989

76. Lindsay RM, Spanner E, Heidenheim P, LeFebvre JMJ, Hodsman A, Baird J, Allison MEM: Which comes first, Kt/V or PCR - chicken or egg? Kidney Int Suppl 42:S32-S36, 1993

77. Delmez JA, Windus DW, St. Louis Nephrology Study Group: Hemodialysis prescription and delivery in a metropolitan community. Kidney Int 41:1023-1028, 1992

78. Lindsay RM, Heidenheim AP, Spanner E, Baird J, Simpson K, Allison ME: Urea monitoring during dialysis: The wave of the future. A tale of two cities. ASAIO Trans 37:49-53, 1991

79. Basile C, Casino F, Lopez T: Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis 15:40-45, 1990

80. Jindal KK, Manuel A, Goldstein MB: Percent reduction in blood urea concentration during hemodialysis (PRU): A simple and accurate method to estimate Kt/V urea. ASAIO Trans 33:286-288, 1987

81. Bankhead MM, Toto RD, Star RA: Accuracy of urea removal estimated by kinetic models. Kidney Int 48:785-793, 1995

82. Burr T: Two-sample hemodialysis urea kinetic modeling: Validation of the method. Nephron 69:49-53, 1995

83. Gabriel JP, Fellay G, Descombes E: Urea kinetic modeling: An in vitro and in vivo comparative study. Kidney Int 46:789-796, 1994

84. Depner T, Cheer A: Modeling urea kinetics with two versus three BUN measurements: A critical comparison. ASAIO Trans 35:499-502, 1989

85. Sargent JA, Gotch FA: Mathematic modeling of dialysis therapy. Kidney Int 18:S2-S10, 1976

86. Sargent JA, Gotch FA: Principles and biophysics of dialysis. in Maher J (ed):Replacement of renal function by dialysis, chap 4. (ed 3), Boston, MA, Kluwer Academic Publishers, 1989, pp 87-143

87. Hume R, Weyers E: Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol 24:234-238, 1971

88. Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33:27-39, 1980

89. Chertow GM, Lowrie EG, Lew NL, Lazarus JM: Development of a population-specific regression equation to estimate total body water in hemodialysis patients. Kidney Int 51:1578-1582, 1997

90. Saha LK, Van Stone JC: Differences between KT/V measured during dialysis and KT/V predicted from manufacturer clearance data. Int J Artif Organs 15:465-469, 1992

91. Garred LJ, Canaud B, Flavier JL, Poux C, Polito-Bouloux C, Mion C: Effect of reuse on dialyzer efficacy. Artif Organs 14:80-84, 1990

92. Evans JH, Smye SW, Brocklebank JT: Mathematical modelling of haemodialysis in children. Pediatr Nephrol 6:349-353, 1992

93. Smye SW, Evans JH, Will E, Brocklebank JT: Paediatric haemodialysis: Estimation of treatment efficiency in the presence of urea rebound. Clin Phys Physiol Meas 13:51-62, 1992

94. Harmon WE: Urea kinetic model to prescribe hemodialysis in children, in Nissenson AR, Fine RN (eds): Dialysis Therapy, chap 30. (ed 2), Philadelphia,PA, Hanley & Belfus, 1993, pp 353-357

95. Harmon WE: Kinetic modeling of haemodialysis in children. Sem Dial 7:392-397, 1994

96. Depner T, Daugirdas JT: Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 7:780-785, 1996

97. Daugirdas JT: Linear estimates of variable-volume, single-pool Kt/V: An analysis of error. Am J Kidney Dis 22:267-270, 1993

98. Sherman RA, Cody RP, Rogers ME, Solanchick JC: Accuracy of the urea reduction ratio in predicting dialysis delivery. Kidney Int 47:319-321, 1995

99. Depner TA: Estimation of Kt/V from the URR for varying levels of dialytic weight loss: A bedside graphic aid. Sem Dial 6:242 1993

100. Garred LJ, Barichello DL, DiGiuseppe B, McCready WG, Canaud BC: Simple Kt/V formulas based on urea mass balance theory. ASAIO J 40:997-1004, 1994

101. Depner TA, Keshaviah PR, Ebben JP, Emerson PF, Collins AJ, Jindal KK, Nissenson AR, Lazarus JM, Pu K: Multicenter clinical validation of an on-line monitor of dialysis adequacy. J Am Soc Nephrol 7:464-471, 1996

102. Garred LJ, St.Amour NR, McCready WG, Canaud BC: Urea kinetic modeling with a prototype urea sensor in the spent dialysate stream. ASAIO J 39:M337-M341, 1993

103. Steil H, Kaufman AM, Morris AT, Levin NW, Polaschegg HD: In vivo verification of an automatic noninvasive system for real time Kt evaluation. ASAIO J 39:M348-M352, 1993

104. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992

105. Uehlinger DE, Keen M, Gotch F: Patient (P) survival with short-time high flux dialysis therapy(HFD). J Am Soc Nephrol 4:392, 1993 (abstr)

106. Capelli JP, Kushner H, Camiscioli T, Chen SM, Stuccio-White NM: Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling; A critical appraisal of shortening dialysis times. Am J Nephrol 12:212-223, 1992

107. Held P: Hemodialysis treatment time: Does it matter? ASAIO J 1997 (In Press)

108. Charra B, Laurent G, Calemard E, Terrat JC, Vanel T, Ruffet M, Chazot C: Survival in dialysis and blood pressure control. Contrib Nephrol 106:179-185, 1994

109. Leblanc M, Charbonneau R, Lalumiere G, Cartier P, Deziel C: Postdialysis urea rebound: Determinants and influence on dialysis delivery in chronic hemodialysis patients. Am J Kidney Dis 27:253-261, 1996

110. Tattersall J, Farrington K, Bowser M, Aldridge C, Greenwood RN, Levin NW: Underdialysis caused by reliance on single pool urea kinetic modeling. J Am Soc Nephrol 3:398 1996

111. Metry GS, Attman PO, Lonnroth P, Beshara SN, Aurell M: Urea kinetics during hemodialysis measured by microdialysis-a novel technique. Kidney Int 44:622-629, 1993

112. Heineken FG, Evans MC, Keen ML, Gotch FA: Intercompartmental fluid shifts in hemodialysis patients. Biotechnol Progr 3:69-73, 1987

113. Depner TA, Rizwan S, Cheer AY, Wagner JM, Eder LA: High venous urea concentrations in the opposite arm: A consequence of hemodialysis-induced compartment disequilibrium. ASAIO Trans 37:M141-M143, 1991

114. Star R, Hootkins J, Thompson J, Poole T, Toto RD: Variability and stability of two pool urea mass transfer coefficient. J Am Soc Nephrol 3:395, 1992 (abstr)

115. Cappello A, Grandi F, Lamberti C, Santoro A: Comparative evaluation of different methods to estimate urea distribution volume and generation rate. Int J Artif Organs 17:322-330, 1994

116. Smye SW, Dunderdale E, Brownridge G, Will E: Estimation of treatment dose in high-efficiency haemodialysis. Rev Enferm 67:24-29, 1994

117. Abramson F, Gibson S, Barlee V, Bosch JP: Urea kinetic modeling at high urea clearances: Implications for clinical practice. Advances in Renal Replacement Therapy 1:5-14, 1994

118. Albouze G, Yanai M, Calamai M, Testou D, Jungers P, Man NK: Urea rebound and residual renal function in the calculation of Kt/V and protein catabolic rate. Kidney Int Suppl 43:S278-S281, 1993

119. Daugirdas JT, Depner TA: A normogram approach to hemodialysis urea modeling. Am J Kidney Dis 23:33-40, 1994

120. Daugirdas JT: Estimation of equilibarated Kt/V using the unequilibrated post dialysis BUN. Sem Dial 8:283-284, 1995

121. Schneditz D, Van Stone JC, Daugirdas JT: A regional blood circulation alternative to in-series two compartment urea kinetic modeling. ASAIO J 39:M573-M577, 1993

122. Spiegel DM, Baker PL, Babcock S, Contiguglia R, Klein M: Hemodialysis urea rebound: The effect of increasing dialysis efficiency. Am J Kidney Dis 25:26-29, 1995

123. Ronco C, Brendolan A, Crepaldi C, La Greca G: Ultrafiltrations-rate und dialyse-hypotension. Dialyse J 40:8-15, 1992

124. Stegeman CA, Huisman RM, de Rouw B, Joostema A, de Jong PE: Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: Urea output measurements compared with dietary protein intake and with calculation of urea generation rate. Am J Kidney Dis 25:887-895, 1995

125. Daugirdas JT, Schneditz D: Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 41:M719-M724, 1995

126. Daugirdas JT, Depner TA, Gotch F, Keshaviah P, Greene T, Schulman G, Levin N: Comparison of methods to predict the equilibrated Kt/V (eKTV) in the hemo study. J Am Soc Nephrol 6:596, 1995 (abstr)

127. Hornberger JC: The hemodialysis prescription and quality-adjusted life expectancy. J Am Soc Nephrol 4:1004-1020, 1993

128. Levin NW, Stannard DC, Gotch F: Comparison of mortality risk (RR) by Kt/V single pool versus double pool (DP) analysis in diabetic and non-diabetic hemodialysis patients. J Am Soc Nephrol (abstract) 6:626 1995

129. Sherman RA, Cody RP, Solanchick JC: Racial differences in the delivery of hemodialysis. Am J Kidney Dis 21:632-634, 1993

130. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: Causes of death in dialysis patients: Racial and gender differences. J Am Soc Nephrol 5:1231-1242, 1994

131. Charra B, Calemard E, Cuche M, Laurent G: Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 33:96-99, 1983

132. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3:1613-1622, 1993

133. LeFebvre JMJ, Spanner E, Heidenheim AP, Lindsay RM: Kt/V: Patients do not get what the physician prescribes. ASAIO Trans 37:M132-M133, 1991

134. Lai YH, Guh JY, Chen HC, Tsai JH: Effects of different sampling methods for measurement of post dialysis blood urea nitrogen on urea kinetic modeling derived parameters in patients undergoing long-term hemodialysis. ASAIO J 41:211-215, 1995

135. Sherman RA, Matera JJ, Novik L, Cody RP: Recirculation reassessed: The impact of blood flow rate and the low-flow method reevaluated. Am J Kidney Dis 23:846-848, 1994

136. Daugirdas JT, Burke MS, Balter P, Priester-Coary A, Majka T: Screening for extreme postdialysis urea rebound using the Smye method: Patients with access recirculation identified when a slow flow method is not used to draw the postdialysis blood. Am J Kidney Dis 28:727-731, 1996

137. Schneditz D, Polaschegg HD, Levin NW, Cu GA, Morris AT, Kramer M, Daugirdas JT, Kaufman AM: Cardiopulmonary recirculation in dialysis: An underrecognized phenomenon. ASAIO J 38:M194-M196, 1992

138. Schneditz D, Kaufman AM, Polaschegg HD, Levin NW, Daugirdas JT: Cardiopulmonary recirculation during hemodialysis. Kidney Int 42:1450-1456, 1992

139. Sherman RA: Recirculation revisited (Editorial). Sem Dial 4:221-223, 1991

140. Feldman HI, Kinosian M, Bilker WB, Simmons C, Holmes JH, Pauly MV, Escarce JJ: Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA 276:620-625, 1996

141. Luehmann DA, Cosentino LC: Safety of dialyzer reuse with renalin: The untold story. Dial Transplant 23:248-258, 1994

142. Morbidity and mortality associated with dialyzer reuse, in Collins A: AAMI Short Course on Dialyzer Reprocessing, AAMI, 1996

143. Collins A, Ma J: Reuse-associated mortality: 1989-90 vs.1991-93. J Am Soc Nephrol 7:1443, 1996 (abstr)

144. Health Care Financing Administration: Condition: Reuse of hemodialyzers and other dialysis supplies. Code of Federal Regulations Title 42:115-116, 1996

145. Gotch FA: Solute and water transport and sterilant removal in reused dialyzers, in Deane N, Wineman RJ, Bemis JA (eds): Guide to Reprocessing of Hemodialyzers, chap 3. Boston, MA, Martinus Nijhoff Publ. 1986, pp 39-61

146. Delmez JA, Weerts CA, Hasamear PD, Windus DW: Severe dialyzer dysfunction undetectable by standard reprocessing validation tests. Kidney Int 36:478-484, 1989

147. Rocco MV, Burkart JM: Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 4:1178-1183, 1993

148. Kinet JP, Soyeur D, Balland N, Saint-Remy M, Collignon P, Godon JP: Hemodynamic study of hypotension during hemodialysis. Kidney Int 21:868-876, 1982

149. De Vries JPPM, Kouw PM, van der Meer NJM, Olthof CG, Oe LP, Donker AJD, de Vries PMJM: Non-invasive monitoring of blood volume during hemodialysis: Its relation with post-dialytic dry weight. Kidney Int 44:851-854, 1993

150. De Vries JPPM, Bogaard HJ, Kouw PM, Oe LP, Stevens P, de Vries PMJM: The adjustment of post dialytic dry weight based on non-invasive measurement of extracellular fluid and blood volumes. ASAIO J 39:M368-M372, 1993

151. Jahn H, Schohn D, Schmitt R: Hemodynamic modifications induced by fluid removal and treatment modalities in chronic hemodialysis patients. Blood Purif 1:80-89, 1983

152. Kirschbaum B: Comparison of indirect methods to estimate plasma volume changes during hemodialysis. Int J Artif Organs 12:307-313, 1989

153. Schallenberg U, Stiller S, Mann H: A new method of continuous haemoglobinometric measurement of blood volume during haemodialysis. Life Support Syst 5:293-305, 1987

154. Bauer H, Franz HE: Influence of variation of ultrafiltration rate on cardiovascular stability during dialysis. Contrib Nephrol 74:154-158, 1989

155. Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM: Acute symptoms during and between hemodialysis: The relative role of speed, duration, and biocompatibility of dialysis. Artif Organs 18:880-887, 1994

156. Steuer RR, Harris DH, Conis JM: A new optical technique for monitoring hematocrit and circulating blood volume: Its application in renal dialysis. Dial Transplant 22:260-265, 1993

157. Sato Y, Iida T, Yamashita M, Sugino K, Sakamaki T, Seto H, Fujibayashi Y, Koike A, Uchiyama T, Kajiwara N: Nature of refractory hypertension and its role in left ventricular function in patients on long-term hemodialysis. Nihon Univ J Med 30:147-156, 1988

158. Bogaard HJ, De Vries JPPM, de Vries PMJM: Assessment of refill and hypovolaemia by continuous surveillance of blood volume and extracellular fluid volume. Nephrol Dial Transplant 9:1283-1287, 1994

159. Rozich JD, Smith B, Thomas JD, Zile MR, Kaiser J, Mann DL: Dialysis-induced alterations in left ventricular filling: Mechanisms and clinical significance. Am J Kidney Dis 17:277-285, 1991

160. Sherman RA, Cody RP, Rogers ME, Solanchick JC: Interdialytic weight gain and nutritional parameters in chronic hemodialysis patients. Am J Kidney Dis 25:579-583, 1995

161. Rouby JJ, Rottembourg J, Durande JP, Basset JY, Degoulet P, Glaser P, Legrain M: Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: A comparative study. Kidney Int 17:801-810, 1980

162. Bradley JR, Evans DB, Cowley AJ: Comparison of vascular tone during combined haemodialysis with ultrafiltration and during ultrafiltration followed by haemodialysis: A possible mechanism for dialysis hypotension. Br Med J 300:1312-1312, 1990

163. Po CL, Afolabi M, Raja RM: The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis. ASAIO J 39:M798-M800, 1993

164. Odar-Cederlof I, Theodorsson E, Eriksson CG, Hamberger B, Tidgren B, Kjellstrand CM: Vasoactive agents and blood pressure regulation in sequential ultrafiltration and hemodialysis. Int J Artif Organs 16:662-669, 1993

165. Farinelli A, Squerzanti R, De Paoli Vitali E, Bagni B, Cavallini AR, Gilli P, Bedani PL: Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis. Nephron 26:274-279, 1980

166. Perschel WT, Rockel A, Klinke B, Reinhardt B, Behnken LJ, Abdelhamid S, Fiegel P, Walb D: Variation of ultrafiltration and dialysate sodium: Beneficial effects on vascular stability in diabetic patients. Contrib Nephrol 74:176-181, 1989

167. Jenson BM, Dobbe SA, Squillace DP, McCarthy JT: Clinical benefits of high and variable sodium concentration dialysate in hemodialysis patients. Am Nephrol Nurses Assoc J 21:115-121, 1994

168. de Vries PMJM, Kouw PM, Olthof CG, Solf A, Schuenemann B, Oe LP, Quellhorst E, Donker AJM: The influence of dialysate sodium and variable ultrafiltration on fluid balance during hemodialysis. ASAIO Trans 36:821-824, 1990

169. Swartz RD, Somermeyer MG, Hsu CH: Preservation of plasma volume during hemodialysis depends on dialysate osmolality. Am J Nephrol 2:189-194, 1982

170. Raja RM, Po CI: Plasma refilling during hemodialysis with decreasing ultrafiltration: Influence of dialysate sodium. ASAIO J 40:M423-M425, 1994

171. Wolff J, Pedersen T, Rossen M, Cleemann-Rasmussen K: Effects of acetate and bicarbonate dialysis on cardiac performance, transmural myocardial perfusion and acid-base balance. Int J Artif Organs 9:105-110, 1986

172. Chen TS, Friedman HS, Smith AJ, Del Monte ML: Hemodynamic changes during hemodialysis: Role of dialyzate. Clin Nephrol 20:190-196, 1983

173. Pagel MD, Ahmad S, Vizzo JE, Scribner BH: Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int 21:513-518, 1982

174. Hakim RM, Pontzer MA, Tilton D, Lazarus JM, Gottlieb MN: Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients. Kidney Int 28:535-540, 1985

175. Sherman RA, Rubin MP, Cody RP, Eisinger RP: Amelioration of hemodialysis-associated hypotension by the use of cool dialysate. Am J Kidney Dis 5:124-127, 1985

176. Yu AW, Ing TS, Zabaneh RI, Daugirdas JT: Effect of dialysate temperature on central hemodynamics and urea kinetics. Kidney Int 48:237-243, 1995

177. Sherman RA, Faustino EF, Bernholc AS, Eisinger RP: Effect of variations in dialysate temperature on blood pressure during hemodialysis. Am J Kidney Dis 4:66-68, 1984

178. Maggiore Q, Pizzarelli F, Sisca S, Zoccali C, Parlongo S, Nicolo F, Creazzo G: Blood temperature and vascular stability during hemodialysis and hemofiltration. Trans Am Soc Artif Intern Organs 28:523-527, 1982

179. Orofino L, Marcen R, Quereda C, Villafruela JJ, Sabater J, Matesanz R, Pascual J, Ortuno J: Epidemiology of symptomatic hypotension in hemodialysis: Is cool dialysate beneficial for all patients. Am J Nephrol 10:177-180, 1990

180. Zoccali C, Mallamaci F, Ciccarelli M, Maggiore Q: Postprandial alterations in arterial pressure control during hemodialysis in uremic patients. Clin Nephrol 31:323-326, 1989

181. Barakat MM, Nawab ZM, Yu AW, Lau AH, Ing TS, Daugirdas JT: Hemodynamic effects of intradialytic food ingestion and the effects of caffeine. J Am Soc Nephrol 3:1813-1818, 1993

182. Sherman RA, Torres F, Cody RP: Postprandial blood pressure changes during hemodialysis. Am J Kidney Dis 12:37-39, 1988

183. Sulkova S, Valek A: Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment. Kidney Int Suppl 34:S198-S200, 1988

184. Salem MM: Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis 26:461-468, 1995

185. Gruenke J, King K: Missouri's Kidney Program's Patient-Education Program: A 10-year review. Dial Transplant 23:691-712, 1994


© 1997 National Kidney Foundation, Inc

Домашняя страница NKF | Общие положения | Анемия | Гемодиализ | Перитонеальный диализ | Сосудистый доступ | Питания